Postoperative Care of Sutured Wounds

Wound Healing Clinical Trial

Official title:

Comparing the Efficacy of Hydrogen Peroxide Versus Normal Saline in Postoperative Care of Sutured Wounds

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02383992
• Other study ID #: STU200234
• Status: Withdrawn
• Phase: N/A
• Start date: October 2015
• Est. completion date: October 1, 2019

Study information

• Verified date: December 2021
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary objective of this study is to compare the efficacy of hydrogen peroxide versus normal saline in postoperative care of sutured wounds. Subjects will be randomly assigned to standard of care hydrogen peroxide or standard of care normal saline in postoperative care of sutured wounds followed by applying petroleum jelly and sterile gauze bandage. Data will be collected at day 0 and between days 7 to14. Subjects will provide irritation scale rating (0-4) with 0 being none/absent and 4 being severe/extreme.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: October 1, 2019
• Est. primary completion date: October 1, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. Patients who are undergoing sutured wound after dermatologic procedure.

2. Males and females ages 18-65 years old.

3. Patients who are in good health.

4. Willingness and the ability to understand and provide informed consent and communicate with the investigator/study staff.

Exclusion Criteria:

1. History of keloids or hypertrophic scars.

2. History of bleeding tendency or coagulopathy.

3. Pregnant or lactating or intends to become pregnant in the next 3 months.

4. Active skin disease or skin infection in the treatment area.

5. Unable to understand the protocol or to give informed consent.

6. Any other condition that would, in the professional opinion of the investigator, potentially affect response or participation in the clinical clinical study, or would pose as an unacceptable risk to the subject.

Related Conditions & MeSH terms

• Wound Healing
• Wounds and Injuries

Intervention

Drug:
• 3% H2O2 solution

• 0.9% normal saline

Locations

Country	Name	City	State
United States	Northwestern University Feinberg School of Medicine, Department of Dermatology	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Irritation scale rating from 1-2 weeks compared to baseline	Subjects will provide irritation scale rating (0-4) with 0 being none/absent and 4 being severe/extreme.	Baseline and 1-2 weeks